Anti-F9/Factor IX Antibody (Emicizumab)
Catalog No.
F1461
Anti-F9/Factor IX Antibody (Emicizumab)
Featured Products
Emicizumab is a bispecific monoclonal antibody that links activated factor IX and activated factor X, replacing the function of the missing activated factor VIII and thus restoring hemostasis. Emicizumab is used in hemophilia A research.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.82 kDa
Dry ice
1610943-06-0
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Hemlibra, ACE910, A44/B26
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P00740
Human
Unconjugated
Monoclonal
Protein A
IgG4
ELISA, FACS, Kinetics, Functional assay, Animal Model
F9 / Factor IX
Please avoid freeze-thaw cycles.